Mapi Pharma Announces Positive Top-Line Results from GA Depot Phase III Trial for…
NESS ZIONA, Israel, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development pharmaceutical company focused on introducing innovative…